Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Ruling affirmed (Rule 36) according to Bloomberg Law reporter
Fifth: Amarin v. Hikma, 21-2024 (Rule 36) affirming D. Nev. ruling declining to allow ad hoc group of physicians, patients, Amarin retail shareholders to intervene and vacate decision invalidating patents on heart treatment Vascepa.
Argued 2/11 before Newman, Dyk, Reyna.
Fifth: Amarin v. Hikma, 21-2024 (Rule 36) affirming D. Nev. ruling declining to allow ad hoc group of physicians, patients, Amarin retail shareholders to intervene and vacate decision invalidating patents on heart treatment Vascepa.
— Perry Cooper (@PerryECooper) February 15, 2022
Argued 2/11 before Newman, Dyk, Reyna.
U.S. Supreme Court snubs Novartis appeal over arthritis drug Enbrel
https://mobile.reuters.com/article/amp/idUSKCN2CY1KQ?__twitter_impression=true
And I expect Pluristem's long-term downtrend from $1000 to $0 resume imminently.
Thanks... I had planned to open an account with LYNX, but had to wait to see how they cope with Brexit. Just saw they moved to Ireland, that's fine with me.
The 8x34 cross definitely is very useful... since you introduced it to me, I use it regularly to time an entry into most of my mid-/long-term holdings too...
I can't even trade most of these tickers with my current account, but I will definitely stick around to watch and learn...
I'm curious - how exactly do you place your SL in these very volatile tickers, and especially when they had a decent run already, but you speculate on them running way higher still?
I was in KTOV and ATNM also... they are (were) great to trade after their offerings.
I have BNGO on my watchlist... BNGO has some really interesting tech, but management and execution is lackluster... I am very surprised that with their history of bad offerings this could run so much... I am quite sure there will be a significant pullback caused by an offering soon... Really surprised they didn't pull the trigger yet... perhaps they have learnt something.
"what is the company supposed to release the results on 1-2 patients?"
Absolutely not, releasing anecdotal results would totally go against NP's modus operandi.
DEEEEBUNKEEEEED!
Lust for Life Mars Booties
HUUUGE MARKET!
Exactly. Much will be forgiven if the trial reads out positively in Jan/Feb and gets EUA, but obviously we didn't make the impact on the pandemic we had hoped for and should have..
Just like Athersys and Pluristem.
OUCH!
What's conjecture? The market is at 30,000 and PSTM didn't participate in any of it. Are you denying that it has been dead money since the $150 high when the Universe of stocks, many pennies, have and are now moving up?
Movie idea: "Amarin - The Revenge of John Thero"
*Four shareholders enter John Thero's office*
SH: "You are under arrest for malfeasance. We, the shareholders and owners of this company will decide your fate.
JT: "I AM THE COMPANY!"
SH: "Not yet!"
JT: "It is treason, then!"
*JT screams and kills three of the SH with his favourite pen*
*A fierce duel between him and the last SH begins; the SH disarms him*
*Joseph Kennedy enters the room*
JT: "Joseph, I can save your paychecks for the next decade!"
SH: "Don't listen to him, Joseph. He is too dangerous to be kept CEO of Amarin" *Prepares to strike him down*
*Kennedy intervenes and cuts both of SH's arm*
JT (screaming): "UNLIMITED EXECUTIVE POWWWWAAA!" *electrocutes SH with his teaser and kicks him out of his office windows*
JT: "You have done well, my conman apprentice! Now bring peace to Amarin, go to the annual shareholder meeting and kill all of them"
JK: "Yes, master..."
What is the difference between successful management and JT?
- It works.
Gimme the OM results already :)
Without solid Phase 2 data, every indication CYDY proposes will be valued at close to zero in such a transaction by a potential suitor, as per industry-standard...
Otherwise Crispr would need to be acquired for 1 trillion, since it has unlimited possibilities...
Remember that they didn't even mention the 30 day interdisciplinary review before the re-submission, which tells me that the required data haven't been put together... Thus it is unlikely, despite what was stated in the filings and the call, that BLA is re-submited by the end of this year...
"I haven't heard anything that is actually new, substantive or even hopeful."
If you mute the call, of course you can't hear anything new...
He is a fully humanized, monoclonal antiDROID
"Rem-death-is-near"
Gave me a good laugh, thanks!
Yes.
Chesspumper also spreading that article everywhere.
Right, because Thursday is the last day of the week.
Thank you!
Has a judge ever changed his vote in an en banc when he was on the panel before?
Seems clever, but why not be more aggressive and throw in that the prima facie obviousness was based on altered evidence and misunderstanding/misrepresentation of facts?
You know, they, um, are working, you know, on a robust response, you know, and strategy, to, you know, maximize SH value, you know!
Soligenix Announces Publication Demonstrating Thermostabilization of Filovirus Vaccine Antigens
- Protein antigen stability after lyophilization demonstrated
- Key analytical assays identified
http://ir.soligenix.com/2020-09-15-Soligenix-Announces-Publication-Demonstrating-Thermostabilization-of-Filovirus-Vaccine-Antigens
Sept 15 presentation
https://www.webcaster4.com/Webcast/Page/2495/37223
Really quiet here... before the storm in Q4?
It'll be a robust presentation, no doubt...
Waiting for a ROBUST CC next week with a ROBUST response by Mr ROBUSTNESS John Thero.
I would take a ROBUST offer ($12) by a ROBUST European BP too...
Wow... how is it possible that judges can disregard all scientific facts and legal errors committed by DuDu?